Skip to content

Pain Informed Movement for People With Knee Osteoarthritis

Pain Informed Movement for People With Knee Osteoarthritis: A Pilot and Feasibility Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05730829
Enrollment
69
Registered
2023-02-16
Start date
2023-04-03
Completion date
2024-12-03
Last updated
2025-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

pain modulation, mind-body exercise

Brief summary

The goal of this clinical trial is to compare a pain informed movement program to standard neuromuscular exercise in people with knee osteoarthritis. The main question it aims to answer are: 1. Are the two interventions a) pain informed movement program plus pain neuroscience education and b) neuromuscular exercise plus standard osteoarthritis education feasible in terms of recruitment, treatment adherence, timelines, data collection procedures, patient follow-up, and resources required? 2. Is there a difference in patient's satisfaction and acceptability of the two programs? 3. Are there any differences in the potential effects of the two programs on subjective pain measures, self-reported function, quality of life, functional leg strength, nervous system pain modulation, brain derived neurotrophic factor and nerve growth factor levels, and psychological factors?

Detailed description

It is critical to understand the underlying mechanism of knee osteoarthritis (OA) pain in order to effectively manage knee OA. It has become clear that alterations in central and peripheral nervous system functioning occurs in people with knee OA and pain sensitization is a common feature. Descending modulation from the central nervous system can facilitate or inhibit nociception. Endogenous pain modulation through the descending system is an important factor as its dysregulation has significant ramifications in pain facilitation and promotion of chronic pain development and maintenance at all levels of the nervous system. The current guidelines lack focus on how to effectively manage it, which is a potential reason for why the current methods in conservative management of knee OA pain are only moderately effective. Mind-body approaches are uniquely positioned to potentially reverse the sensitization, induce positive neuroplastic changes, and improve descending pain modulation resulting in decreased pain intensity in many chronic pain populations. This study involves an exercise program which the investigators call 'Pain Informed Movement' that includes evidence-based exercises combined with mind-body techniques and pain neuroscience education. The data from this phase will be used to inform a multi-site randomized controlled trial (RCT) to assess the program's effectiveness with the primary outcome of change in pain severity mediated by change in descending pain modulation. Exercise is regularly used as a first-line management option for knee OA, and its use is supported by high quality evidence to improve pain and function. Clinical practice guidelines for people with knee OA recommend the use of aerobic and strength training for the reduction of pain and improved physical function. Currently, one of the key components of conservative management of knee OA often implemented by clinicians is a type of exercise called neuromuscular exercise, which aims at improving sensorimotor control and the functionality of the knee joint by addressing movement in all three movement planes. Previous research has showed that the neuromuscular exercise programs designed specifically for knee OA can reduce pain, improve function, alter knee biomechanics, and improve the muscle-activation patterns of the surrounding knee musculature. While exercise is the first line treatment for knee OA and can lead to improvements in physical function and pain, it is important to highlight that it has a moderate effect, which may be short term. In recent years multiple guidelines for non-surgical management of knee OA have begun to include mind-body therapies, such as yoga or tai-chi, as conditional or core treatment recommendations. Mind-body therapies can lead to pain reductions and improvement of function through various techniques. For instance, breathing exercises including breath awareness and regulation can activate the parasympathetic nervous system and decrease the danger signals of pain, leading to improvement of pain levels. Meditative breathing can lead to reductions in pain levels by modulating the somatosensory cortex. Relaxation techniques focused on relaxing the muscles that become tense as a result of pain and by association can re-enforce or aggravate pain, can influence the pain experience by reversing that association. Mindfulness meditation and mindful movement which can lead to a switch from sensory pain to the interoceptive awareness of the movements of the different body parts, resulting in reduced muscle tension, improvements in postural stability and proprioception, and reductions in pain levels. Mind-body therapies also lead to improvement of psychological factors such as depression, anxiety, pain catastrophizing, increasing pain acceptance, changing patients' relationships to their pain, which in turn lead to reductions in pain levels. The positive effects of mindfulness practices have been reported to last in longer-term follow ups such as 15 months, and 3 years. Education is another core component recommended by clinical guidelines and known to be effective particularly when combined with exercise. Pain Neuroscience education (PNE) is an alternative technique of teaching patients about pain and how to rethink and re-evaluate the way pain is viewed. The use of PNE in physical therapy interventions has been steadily increasing due to its positive effects on pain and function in many chronic pain patient populations. PNE includes an explanation of the neurophysiology of pain and its process by the nervous system. This includes how pain can be modulated through upregulation or downregulation of signals to increase or decrease the pain experience and that these changes are not necessarily related to tissue damage, particularly when pain becomes chronic. PNE also provides information regarding the influence of various psychosocial aspects. By offering avenues to reconceptualize pain as a threat to the body and movement as imminent danger, patients may become more willing to participate in physical activity and tolerate slight increases in pain and discomfort. In contrast standard OA education is the traditional and most widely used educational model in people with knee OA, focuses heavily on a pathoanatomical perspective of pain referring mainly to anatomy, biomechanics, and patho-anatomy of OA and the knee joint. Given the importance of finding effective management strategies for pain modulation in people with knee OA, there is a need to further our understanding of the impact of evidence-based exercise combined with mind-body techniques (e.g., breathing exercises and mindfulness) with PNE on pain mechanisms. The study is a pilot RCT with a nested qualitative component. The study will be guided by the Conceptual Framework for Defining Feasibility and Pilot studies and the Standard Protocol Items: Recommendations for Intervention Trials. Study Population A sample of 66 adults will be sought. The sample size is based on the primary outcome of complete follow-up using the confidence interval method for calculating sample size in pilot trials. 90% follow-up rate is the aim but the trial will be considered successful if 81% is achieved. To achieve a margin of error of 9%, with 10% added for attrition, 66 participants is required. Recruitment Participants will be recruited through the email lists of the McMaster Physical Activity Centre of Excellence (PACE) community and the McMaster Institute for Research on Aging (MIRA) newsletter. Postings will be placed on both PACE and MIRA social media pages. In addition, the study poster will be placed on other social media channels (i.e., Twitter, Facebook advertisements). In addition, flyers will be placed in local orthopaedic surgeon, Rheumatologist and Physiatrists offices. Physicians will provide potential participants with a one-page study information sheet in lay language. If interested, potential participants can then contact the research team through the contact information provided in the flyer. Setting The in-person 8-week exercise program will be held twice weekly at McMaster University's Physical Activity Centre of Excellence (PACE) located in the Ivor-Wynne Centre or in one of two local community churches. Participants will complete the pain assessment, and have blood drawn at PACE by PACE staff who are certified phlebotomists. Assessment As part of participation in the study, participants will be asked to attend an assessment at the beginning of the study, and once again upon completing the 8-week exercise program. Participants will conditioned undergo pain modulation (CPM) and mechanical temporal summation testing, and the 30 Second Sit to Stand Test to determine leg strength and endurance. Lastly, participants will have their blood drawn (fasting) at the beginning and end of the study. Participants will then be asked to complete a series of questionnaires about their pain and mood. Interventions Twice weekly group exercise sessions will be 75 minutes for the intervention group and 60 minutes in duration for the control group. The intervention arm class is slightly longer due to the detailed delivery of instructions for the techniques during the class. Participants will be given instructions to complete these exercises at home at least one other time during the week for the same duration. Participants will receive education videos that are \ 15-20 minutes each week, for up to 4 weeks. Pain Informed Movement and PNE - During the neuromuscular exercise sessions, the PNE components and concepts such as mindfulness, muscle tension regulation, and breathing techniques will be applied by the instructor. Neuromuscular exercise and standard OA education - The exercise component (i.e., the specific movements) of this group will be similar to those of the intervention group without the added mind-body techniques. Randomization and allocation concealment Participants will be randomized with an allocation ratio of 1:1 into one of two treatment groups (Pain informed movement and PNE versus neuromuscular exercise and standard OA education) using a REDCap randomization module. Following consent and completion of baseline assessment, the assessor (different person than the recruiter) will log in to the website, open the participants' identification record and click on the randomize button. Randomization will be blocked and this process will ensure allocation concealment. As allocation concealment occurs following the baseline assessment, the assessors will be blinded at baseline and follow up assessment. Blinding of instructors is generally not possible in studies of physical interventions (i.e., exercise). Participants will be blinded to study hypotheses and the two treatment groups. As both arms of the study are providing exercise based interventions and education, participants will be provided limited details of each intervention arm so as to blind them from knowing which is the intervention and which is the control. This will help minimize any bias that occurs by knowledge of group assignment and perception of treatment effects. Exit Survey and Focus Group In addition to the primary and secondary outcomes, a satisfaction survey will be conducted at the end of the program to evaluate the a priori feasibility criteria. Participants who indicated upon initially consenting to the study that would like to participate in a focus group, will be contacted. Qualitative data collection will be used to explore participants experience and perceptions of the feasibility and acceptability of the program. A focus group will be conducted using audio or video recording (using Zoom), lasting between 45-60 minutes.

Interventions

group classes twice weekly for 8 weeks of neuromuscular exercise in combination with mind-body techniques such as breath regulation, muscle tension regulation, relaxation, mindfulness, awareness of pain related thoughts and emotions.

OTHERstandard neuromuscular exercise

group classes twice weekly for 8 weeks of neuromuscular exercise.

The pain neuroscience education (PNE) will be delivered in videos addressing concepts such as the purpose of pain, neurophysiological changes of pain, movement guidelines when pain persists, and self-care techniques to impact neurophysiology and support moving with ease that include breath awareness and regulation, muscle tension regulation, awareness of pain related thoughts and emotions, relaxation, and body awareness.

OTHERStandard osteoarthritis (OA) education

The standard osteoarthritis (OA) education will address the following topics, OA prevalence, risk factors, symptoms, diagnosis, treatment, role of exercise, surgery, self-management

Sponsors

Boston University
CollaboratorOTHER
University of Melbourne
CollaboratorOTHER
University of British Columbia
CollaboratorOTHER
McMaster University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* \- ≥40 years of age with diagnosis of knee osteoarthritis (OA) by a physician OR; * ≥45 years of age and having activity-related knee joint pain with or without morning stiffness lasting 30 minutes (NICE criteria) * Having an average pain intensity of 3/10 on a numeric pain scale on most days of the past month

Exclusion criteria

* Cannot communicate in English; * Has inflammatory arthritis or other systemic conditions; * Have had lower limb trauma or surgery within the past 6 months; * Have participated in a knee OA exercise program in the prior 3 months; * Have had any injection in the index knee within 3-months prior to baseline assessment * Does not have regular access to the internet * Inability to get up and down from the floor independently * Use of mobility aids * Currently participating in any other drug/device/exercise clinical trial related to OA * Planned absences (e.g., trips away) of \>1 week * Currently receiving other forms of care for knee OA pain (e.g., from a physiotherapist, chiropractor, athletic therapist, kinesiologist) * Does not meet screening for safe participation in exercise according to the Get Active questionnaire from the Canadian Society for Exercise Physiology

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Follow up8 weeksThe follow-up rate is calculated as the number (percentage) of participants who completed the study out of those who completed the baseline assessment.

Secondary

MeasureTime frameDescription
Number of Participants Who Considered the Program Frequent Enough8 weeksThis outcome measure represents the number of participants who rated the program's frequency as Frequent enough on a 5-point Likert scale. The scale ranged from Not frequent enough to Frequent enough, capturing participants' satisfaction with the program's scheduling.
Number of Participants Who Considered the Educational Session Frequency Enough8 weeksThis outcome measure represents the number of participants who rated the frequency of the educational sessions as Frequent enough on a 5-point Likert scale. The scale ranged from Not frequent enough to Frequent enough, assessing participants' satisfaction with the scheduling of the sessions.
Rate of Recruitment Measured by Number of People Recruited in a Year1 yearrecruitment rate is a minimum of 40 people in a year
Number of Participants Who Considered the Program Useful and Very Useful8 weeksthe number of participants who found the program useful or very useful. Participants rated the program's usefulness on a Likert scale, ranging from Not useful at all to Very useful. The final count reflects those who selected either of the top two response categories, indicating a positive perception of the program's value.
Rate of Adherence Measured by Number of Sessions Attended and Home Sessions Completed8 weeksThis outcome measure evaluates adherence to the program by calculating the number of sessions attended in-person and the number of home sessions completed by participants. The rate of adherence is determined by the proportion of sessions attended and completed relative to the total number of scheduled sessions.
Rate of Adverse Events Measured by Question Regarding Symptom Flare and Seeking Treatment8 weeksmeasured as any problem that lasts for \>2 days and/or causes the participant to seek other treatment
Percentage of Participants Who Did Not Find the Study Procedures Burdensome (Questionnaires, Tests, Blood Draws) Measured on 0-10 Scale8 weeksThis outcome measure represents the percentage of participants who rated the program's burdensomeness as zero, using a scale from 0 (No burden at all) to 10 (Very much a burden). Participants who provided a low burden rating (≤3/10) are included in this percentage, indicating that they did not perceive the program as burdensome.

Other

MeasureTime frameDescription
Pain Intensity Measured on the Numeric Rating Scale (NRS)baseline and 8 weeksThis outcome measure assesses pain intensity using the Numeric Rating Scale (NRS), where participants rate their pain on a scale from 0 to 10, with higher scores indicating greater pain severity. Three ratings are recorded: average pain intensity in the past 24 hours, average pain intensity in the past week, and worst pain intensity in the past 24 hours.
Pain Catastrophizing Scale (PCS)baseline and 8 weeks13 questions for a total score of 52 with higher scores indicating more severe symptoms. Minimum score = 0, maximum score 52
Self-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD-6)baseline and 8 weeksmeasure of self-efficacy rated on 0-10 scale ranging from not at all confident to entirely confident
Hospital Anxiety and Depression Scale (HADS)baseline and 8 weeksThis outcome measure assesses symptoms of anxiety and depression using the Hospital Anxiety and Depression Scale (HADS). The HADS consists of 14 items, with seven items assessing anxiety (HADS-A) and seven assessing depression (HADS-D). Each item is scored on a 0 to 3 scale, resulting in total scores ranging from 0 to 21 for both anxiety and depression subscales. Higher scores indicate greater levels of anxiety or depression,
Brief Fear of Movement Scale for Osteoarthritis (BFMSO)Baseline and 8 weeksThis outcome measure assesses fear of movement (kinesiophobia) in individuals with osteoarthritis using the Brief Fear of Movement Scale for Osteoarthritis (BFMSO). The BFMSO consists of six items derived from the Tampa Scale for Kinesiophobia (TSK) and is rated on a 4-point Likert scale (1-4), with a total score range of 6 to 24, where higher scores indicate greater levels of kinesiophobia. The scale evaluates concerns about movement due to pain or the fear of worsening symptoms, providing insight into the psychological barriers that may affect physical activity and rehabilitation adherence in individuals with osteoarthritis.
Modified Charlson Comorbidity Indexbaselineto assesses the presence of comorbidities minimum score = 0, maximum = 20 with higher scores indicating greater severity.
Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Versionbaseline and 8 weeksThe ICOAP (Intermittent and Constant Osteoarthritis Pain) Knee Version assesses two distinct types of knee pain: constant pain and intermittent pain. The constant pain subscale consists of five items that evaluate pain that is present all the time. Each item is rated on a scale from 0 to 4, where 0 represents no pain, 1 indicates mild pain, 2 corresponds to moderate pain, 3 signifies severe pain, and 4 represents extreme pain. The total score for this subscale ranges from 0 to 20, with higher scores reflecting greater pain severity. Similarly, the intermittent pain subscale comprises six items that assess pain that comes and goes in episodes. Each item follows the same 0 to 4 rating scale, capturing the intensity of episodic pain experiences. The total score for this subscale ranges from 0 to 24. The overall ICOAP knee score is the sum of both subscales, resulting in a total score range of 0 to 44, where higher scores indicate more severe and impactful knee pain.
30 Second Sit to Stand Testbaseline and 8 weeksto measure functional leg strength and endurance by counting the numbers of complete movements accomplished in the allotted time
Serum Levels of Brain Derived Neurotrophic Factors (BDNF) Via Blood Analysisbaseline and 8 weeksa neurotrophin level measured in pg/ml
Serum Levels of Nerve Growth Factor (NGF) Via Blood Analysisbaseline and 8 weeksa neurotrophin level measured in pg/ml
Perspectives on the Effectiveness of the Different Intervention Components on Managing Pain8 weeksOne question will be asked of participants in each arm to rank the effectiveness of the different components of the intervention they received. e.g. Please rank the different components of the intervention you received in order of how effective they are for managing your pain. A list of the different components in each study arm will be provided e.g. education videos, strengthening exercise, mind-body techniques
Knee Injury and Osteoarthritis Outcome Score (KOOS)baseline and 8 weeksThe KOOS pain and function in daily living and QoL subscales were used to assess self-reported opinions about patients' knee and associated problems. Scores ranged from 0-100 with zero representing extreme knee problems and 100 representing no knee problems
Participant CharacteristicsbaselineEthnicity
Weightbaseline and 8 weeksWeight
Number of Participants With Medication Usebaseline and 8 weeksThis outcome measure represents the number of participants who reported taking any medication on a regular schedule. Medication use was assessed with a yes/no response, where participants indicated whether they consistently take any prescribed or over-the-counter medications.
Perspectives on Knee Replacement Surgerybaseline and 8 weeksThree questions will be asked: 1. Are your knee symptoms so severe that you wish to undergo knee replacement surgery? 2. Do you think knee replacement surgery is eventually inevitable? 3. In your opinion, what factor(s) can lead to better outcomes after knee replacement surgery?
Other Painful Body Partsbaseline and 8 weeksUsing a body diagram, participants will be asked to indicate any other areas where they experience pain
Mechanical Temporal Summation (TS)baseline and 8 weeksA 512mN weighted probe was applied at the volar wrist opposite to the index knee. Participants were asked to rate their pain on a scale from 0 (no pain) to 100 (worst imaginable pain). Then, the same stimulus was applied 10 times at a rate of 1 per second (guided by a metronome), and participants were again asked to rate their pain. Temporal Summation (TS) was defined as present if the pain rating after the repeated stimuli was higher than the initial pain rating. The TS score was calculated as the difference between the pain rating after the repeated stimuli and the initial pain rating at each timepoint.
Conditioned Pain Modulation (CPM) Measured With PPT Test Stimulus and Conditioning Stimulus of Forearm Ischemiabaseline and 8 weeksFirst stimulus of pressure pain threshold is delivered, next ischemic forearm test is conducted to a 4/10 and then PPT is repeated. An index will be created by calculating the percent efficiency of CPM (%CPM) as PPT2/PPT1, multiplied by 100; whereby %CPM ≤ 100 indicates inefficient pain modulation CPM. There are no standard minimum or maximum values.

Countries

Canada

Participant flow

Pre-assignment details

NA. we did not have any significant event prior to assignment of participants to an arm.

Participants by arm

ArmCount
Pain Informed Movement and Pain Neuroscience Education
Participants will engage in a twice-weekly, 8-week in-person group exercise program, combining neuromuscular exercise and mind-body techniques. Each session includes 75 minutes of exercise instruction and, during the first four weeks, 20 to 30 minutes of Pain Neuroscience Education (PNE) videos. A third weekly home session will be supported by exercise handouts. The exercise component will be led by an experienced yoga instructor trained extensively in pain-informed movement, incorporating techniques such as breath regulation, muscle tension regulation, relaxation, mindfulness, and awareness of pain-related thoughts and emotions. The PNE videos will cover key topics: the purpose of pain, neurophysiological changes in pain, movement strategies when pain persists, and self-care techniques to influence neurophysiology. These include breath awareness, muscle tension regulation, and relaxation methods aimed at supporting movement with greater ease while fostering body awareness and emotional regulation.
28
Standard Neuromuscular Exercise and OA Education
Participants in this group will receive an 8-week in-person group exercise program held twice weekly, in which they will receive exercise instructions (60 minutes) and standard osteoarthritis (OA) education (15 to 20 minutes/week for the first 4 weeks). A third home session (weekly) will be facilitated by exercise handout sheets. The exercise component (i.e., the specific movements) of this group will be similar to those of the other group without the added techniques of breath awareness and regulation, muscle tension regulation, awareness of pain related thoughts and emotions, relaxation, and body awareness. The standard OA education videos will cover the following topics: common OA symptoms, risk factors associated with knee OA, and the effects of exercise and self-management tips. The exercise and education components will be delivered by a physiotherapist in the research team. standard neuromuscular exercise: group classes twice weekly for 8 weeks of neuromuscular exercise. Standard osteoarthritis (OA) education: The standard osteoarthritis (OA) education will address the following topics, OA prevalence, risk factors, symptoms, diagnosis, treatment, role of exercise, surgery, self-management
31
Total59

Baseline characteristics

CharacteristicStandard Neuromuscular Exercise and OA EducationTotalPain Informed Movement and Pain Neuroscience Education
Age, Continuous62 years
STANDARD_DEVIATION 10
63 years
STANDARD_DEVIATION 10
64 years
STANDARD_DEVIATION 9
Race (NIH/OMB)
American Indian or Alaska Native
28 Participants53 Participants25 Participants
Race (NIH/OMB)
Asian
2 Participants4 Participants2 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Sex: Female, Male
Female
19 Participants42 Participants23 Participants
Sex: Female, Male
Male
12 Participants17 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 340 / 35
other
Total, other adverse events
0 / 340 / 35
serious
Total, serious adverse events
0 / 340 / 35

Outcome results

Primary

Percentage of Follow up

The follow-up rate is calculated as the number (percentage) of participants who completed the study out of those who completed the baseline assessment.

Time frame: 8 weeks

Population: This is the number of participants at baseline who completed the baseline assessments and enrolled in the study.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Pain Informed Movement and Pain Neuroscience EducationPercentage of Follow up28 Participants
Standard Neuromuscular Exercise and OA EducationPercentage of Follow up31 Participants
Secondary

Number of Participants Who Considered the Educational Session Frequency Enough

This outcome measure represents the number of participants who rated the frequency of the educational sessions as Frequent enough on a 5-point Likert scale. The scale ranged from Not frequent enough to Frequent enough, assessing participants' satisfaction with the scheduling of the sessions.

Time frame: 8 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Pain Informed Movement and Pain Neuroscience EducationNumber of Participants Who Considered the Educational Session Frequency Enough24 Participants
Standard Neuromuscular Exercise and OA EducationNumber of Participants Who Considered the Educational Session Frequency Enough25 Participants
Secondary

Number of Participants Who Considered the Program Frequent Enough

This outcome measure represents the number of participants who rated the program's frequency as Frequent enough on a 5-point Likert scale. The scale ranged from Not frequent enough to Frequent enough, capturing participants' satisfaction with the program's scheduling.

Time frame: 8 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Pain Informed Movement and Pain Neuroscience EducationNumber of Participants Who Considered the Program Frequent Enough24 Participants
Standard Neuromuscular Exercise and OA EducationNumber of Participants Who Considered the Program Frequent Enough25 Participants
Secondary

Number of Participants Who Considered the Program Useful and Very Useful

the number of participants who found the program useful or very useful. Participants rated the program's usefulness on a Likert scale, ranging from Not useful at all to Very useful. The final count reflects those who selected either of the top two response categories, indicating a positive perception of the program's value.

Time frame: 8 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Pain Informed Movement and Pain Neuroscience EducationNumber of Participants Who Considered the Program Useful and Very Useful25 Participants
Standard Neuromuscular Exercise and OA EducationNumber of Participants Who Considered the Program Useful and Very Useful29 Participants
Secondary

Percentage of Participants Who Did Not Find the Study Procedures Burdensome (Questionnaires, Tests, Blood Draws) Measured on 0-10 Scale

This outcome measure represents the percentage of participants who rated the program's burdensomeness as zero, using a scale from 0 (No burden at all) to 10 (Very much a burden). Participants who provided a low burden rating (≤3/10) are included in this percentage, indicating that they did not perceive the program as burdensome.

Time frame: 8 weeks

Population: The percentage of the participants per arm who did not find the study procedures burdensome.

ArmMeasureGroupValue (NUMBER)
Pain Informed Movement and Pain Neuroscience EducationPercentage of Participants Who Did Not Find the Study Procedures Burdensome (Questionnaires, Tests, Blood Draws) Measured on 0-10 ScaleBurden of questionnaires69 percentage of the participants
Pain Informed Movement and Pain Neuroscience EducationPercentage of Participants Who Did Not Find the Study Procedures Burdensome (Questionnaires, Tests, Blood Draws) Measured on 0-10 ScaleBurden of physical assessments83 percentage of the participants
Standard Neuromuscular Exercise and OA EducationPercentage of Participants Who Did Not Find the Study Procedures Burdensome (Questionnaires, Tests, Blood Draws) Measured on 0-10 ScaleBurden of questionnaires87 percentage of the participants
Standard Neuromuscular Exercise and OA EducationPercentage of Participants Who Did Not Find the Study Procedures Burdensome (Questionnaires, Tests, Blood Draws) Measured on 0-10 ScaleBurden of physical assessments94 percentage of the participants
Secondary

Rate of Adherence Measured by Number of Sessions Attended and Home Sessions Completed

This outcome measure evaluates adherence to the program by calculating the number of sessions attended in-person and the number of home sessions completed by participants. The rate of adherence is determined by the proportion of sessions attended and completed relative to the total number of scheduled sessions.

Time frame: 8 weeks

Population: This is the total number of possible sessions for each group (16 sessions \* Number of participants per group)

ArmMeasureValue (NUMBER)
Pain Informed Movement and Pain Neuroscience EducationRate of Adherence Measured by Number of Sessions Attended and Home Sessions Completed396 number of sessions attended in each grou
Standard Neuromuscular Exercise and OA EducationRate of Adherence Measured by Number of Sessions Attended and Home Sessions Completed425 number of sessions attended in each grou
Secondary

Rate of Adverse Events Measured by Question Regarding Symptom Flare and Seeking Treatment

measured as any problem that lasts for \>2 days and/or causes the participant to seek other treatment

Time frame: 8 weeks

ArmMeasureValue (NUMBER)
Pain Informed Movement and Pain Neuroscience EducationRate of Adverse Events Measured by Question Regarding Symptom Flare and Seeking Treatment0 Number of adverse events
Standard Neuromuscular Exercise and OA EducationRate of Adverse Events Measured by Question Regarding Symptom Flare and Seeking Treatment0 Number of adverse events
Secondary

Rate of Recruitment Measured by Number of People Recruited in a Year

recruitment rate is a minimum of 40 people in a year

Time frame: 1 year

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Pain Informed Movement and Pain Neuroscience EducationRate of Recruitment Measured by Number of People Recruited in a Year28 Participants
Standard Neuromuscular Exercise and OA EducationRate of Recruitment Measured by Number of People Recruited in a Year31 Participants
Other Pre-specified

30 Second Sit to Stand Test

to measure functional leg strength and endurance by counting the numbers of complete movements accomplished in the allotted time

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience Education30 Second Sit to Stand TestBaseline13.8 repetitionsStandard Deviation 3.3
Pain Informed Movement and Pain Neuroscience Education30 Second Sit to Stand TestFollow-up17 repetitionsStandard Deviation 4
Standard Neuromuscular Exercise and OA Education30 Second Sit to Stand TestBaseline11.9 repetitionsStandard Deviation 2.6
Standard Neuromuscular Exercise and OA Education30 Second Sit to Stand TestFollow-up15 repetitionsStandard Deviation 4
Other Pre-specified

Brief Fear of Movement Scale for Osteoarthritis (BFMSO)

This outcome measure assesses fear of movement (kinesiophobia) in individuals with osteoarthritis using the Brief Fear of Movement Scale for Osteoarthritis (BFMSO). The BFMSO consists of six items derived from the Tampa Scale for Kinesiophobia (TSK) and is rated on a 4-point Likert scale (1-4), with a total score range of 6 to 24, where higher scores indicate greater levels of kinesiophobia. The scale evaluates concerns about movement due to pain or the fear of worsening symptoms, providing insight into the psychological barriers that may affect physical activity and rehabilitation adherence in individuals with osteoarthritis.

Time frame: Baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience EducationBrief Fear of Movement Scale for Osteoarthritis (BFMSO)Baseline10.3 Total score on a scaleStandard Deviation 2.7
Pain Informed Movement and Pain Neuroscience EducationBrief Fear of Movement Scale for Osteoarthritis (BFMSO)Follow-up11.8 Total score on a scaleStandard Deviation 2.1
Standard Neuromuscular Exercise and OA EducationBrief Fear of Movement Scale for Osteoarthritis (BFMSO)Baseline10.4 Total score on a scaleStandard Deviation 3.1
Standard Neuromuscular Exercise and OA EducationBrief Fear of Movement Scale for Osteoarthritis (BFMSO)Follow-up10.7 Total score on a scaleStandard Deviation 3.1
Other Pre-specified

Conditioned Pain Modulation (CPM) Measured With PPT Test Stimulus and Conditioning Stimulus of Forearm Ischemia

First stimulus of pressure pain threshold is delivered, next ischemic forearm test is conducted to a 4/10 and then PPT is repeated. An index will be created by calculating the percent efficiency of CPM (%CPM) as PPT2/PPT1, multiplied by 100; whereby %CPM ≤ 100 indicates inefficient pain modulation CPM. There are no standard minimum or maximum values.

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience EducationConditioned Pain Modulation (CPM) Measured With PPT Test Stimulus and Conditioning Stimulus of Forearm IschemiaBaselin110.4 score on a scaleStandard Deviation 23.7
Pain Informed Movement and Pain Neuroscience EducationConditioned Pain Modulation (CPM) Measured With PPT Test Stimulus and Conditioning Stimulus of Forearm IschemiaFollow-up120 score on a scaleStandard Deviation 33.4
Standard Neuromuscular Exercise and OA EducationConditioned Pain Modulation (CPM) Measured With PPT Test Stimulus and Conditioning Stimulus of Forearm IschemiaBaselin102.2 score on a scaleStandard Deviation 34.7
Standard Neuromuscular Exercise and OA EducationConditioned Pain Modulation (CPM) Measured With PPT Test Stimulus and Conditioning Stimulus of Forearm IschemiaFollow-up109.1 score on a scaleStandard Deviation 32.2
Other Pre-specified

Hospital Anxiety and Depression Scale (HADS)

This outcome measure assesses symptoms of anxiety and depression using the Hospital Anxiety and Depression Scale (HADS). The HADS consists of 14 items, with seven items assessing anxiety (HADS-A) and seven assessing depression (HADS-D). Each item is scored on a 0 to 3 scale, resulting in total scores ranging from 0 to 21 for both anxiety and depression subscales. Higher scores indicate greater levels of anxiety or depression,

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience EducationHospital Anxiety and Depression Scale (HADS)Anxiety Baseline5.2 score on a scaleStandard Deviation 3.2
Pain Informed Movement and Pain Neuroscience EducationHospital Anxiety and Depression Scale (HADS)Depression Baseline3.6 score on a scaleStandard Deviation 2.3
Pain Informed Movement and Pain Neuroscience EducationHospital Anxiety and Depression Scale (HADS)Anxiety Follow-up5.2 score on a scaleStandard Deviation 3.1
Pain Informed Movement and Pain Neuroscience EducationHospital Anxiety and Depression Scale (HADS)Depression follow-up3.7 score on a scaleStandard Deviation 2.3
Standard Neuromuscular Exercise and OA EducationHospital Anxiety and Depression Scale (HADS)Depression follow-up3.8 score on a scaleStandard Deviation 2.9
Standard Neuromuscular Exercise and OA EducationHospital Anxiety and Depression Scale (HADS)Anxiety Baseline4.9 score on a scaleStandard Deviation 3
Standard Neuromuscular Exercise and OA EducationHospital Anxiety and Depression Scale (HADS)Anxiety Follow-up4.2 score on a scaleStandard Deviation 3.6
Standard Neuromuscular Exercise and OA EducationHospital Anxiety and Depression Scale (HADS)Depression Baseline4.9 score on a scaleStandard Deviation 3
Other Pre-specified

Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version

The ICOAP (Intermittent and Constant Osteoarthritis Pain) Knee Version assesses two distinct types of knee pain: constant pain and intermittent pain. The constant pain subscale consists of five items that evaluate pain that is present all the time. Each item is rated on a scale from 0 to 4, where 0 represents no pain, 1 indicates mild pain, 2 corresponds to moderate pain, 3 signifies severe pain, and 4 represents extreme pain. The total score for this subscale ranges from 0 to 20, with higher scores reflecting greater pain severity. Similarly, the intermittent pain subscale comprises six items that assess pain that comes and goes in episodes. Each item follows the same 0 to 4 rating scale, capturing the intensity of episodic pain experiences. The total score for this subscale ranges from 0 to 24. The overall ICOAP knee score is the sum of both subscales, resulting in a total score range of 0 to 44, where higher scores indicate more severe and impactful knee pain.

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience EducationIntermittent and Constant Osteoarthritis Pain (ICOAP) Knee VersionConstant Pain - Baseline6.9 score on a scaleStandard Deviation 3.3
Pain Informed Movement and Pain Neuroscience EducationIntermittent and Constant Osteoarthritis Pain (ICOAP) Knee VersionIntermittent Pain- Baseline10.2 score on a scaleStandard Deviation 4
Pain Informed Movement and Pain Neuroscience EducationIntermittent and Constant Osteoarthritis Pain (ICOAP) Knee VersionConstant Pain - Follow-up4.4 score on a scaleStandard Deviation 3.4
Pain Informed Movement and Pain Neuroscience EducationIntermittent and Constant Osteoarthritis Pain (ICOAP) Knee VersionIntermittent Pain- Follow up7.5 score on a scaleStandard Deviation 4.2
Pain Informed Movement and Pain Neuroscience EducationIntermittent and Constant Osteoarthritis Pain (ICOAP) Knee VersionTotal Score Baseline17.2 score on a scaleStandard Deviation 6.3
Pain Informed Movement and Pain Neuroscience EducationIntermittent and Constant Osteoarthritis Pain (ICOAP) Knee VersionTotal Score Follow up11.8 score on a scaleStandard Deviation 7.3
Standard Neuromuscular Exercise and OA EducationIntermittent and Constant Osteoarthritis Pain (ICOAP) Knee VersionTotal Score Baseline16.1 score on a scaleStandard Deviation 7.1
Standard Neuromuscular Exercise and OA EducationIntermittent and Constant Osteoarthritis Pain (ICOAP) Knee VersionConstant Pain - Baseline5.5 score on a scaleStandard Deviation 3.9
Standard Neuromuscular Exercise and OA EducationIntermittent and Constant Osteoarthritis Pain (ICOAP) Knee VersionIntermittent Pain- Follow up7 score on a scaleStandard Deviation 3.8
Standard Neuromuscular Exercise and OA EducationIntermittent and Constant Osteoarthritis Pain (ICOAP) Knee VersionIntermittent Pain- Baseline10.4 score on a scaleStandard Deviation 3.6
Standard Neuromuscular Exercise and OA EducationIntermittent and Constant Osteoarthritis Pain (ICOAP) Knee VersionTotal Score Follow up11.1 score on a scaleStandard Deviation 6.7
Standard Neuromuscular Exercise and OA EducationIntermittent and Constant Osteoarthritis Pain (ICOAP) Knee VersionConstant Pain - Follow-up4.2 score on a scaleStandard Deviation 3.7
Other Pre-specified

Knee Injury and Osteoarthritis Outcome Score (KOOS)

The KOOS pain and function in daily living and QoL subscales were used to assess self-reported opinions about patients' knee and associated problems. Scores ranged from 0-100 with zero representing extreme knee problems and 100 representing no knee problems

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience EducationKnee Injury and Osteoarthritis Outcome Score (KOOS)Pain baseline55.3 score on a scaleStandard Deviation 12.7
Pain Informed Movement and Pain Neuroscience EducationKnee Injury and Osteoarthritis Outcome Score (KOOS)Function baseline70.5 score on a scaleStandard Deviation 12.1
Pain Informed Movement and Pain Neuroscience EducationKnee Injury and Osteoarthritis Outcome Score (KOOS)QL baseline23.6 score on a scaleStandard Deviation 15.9
Pain Informed Movement and Pain Neuroscience EducationKnee Injury and Osteoarthritis Outcome Score (KOOS)Pain follow-up67.4 score on a scaleStandard Deviation 13.5
Pain Informed Movement and Pain Neuroscience EducationKnee Injury and Osteoarthritis Outcome Score (KOOS)Function follow-up77.2 score on a scaleStandard Deviation 12.1
Pain Informed Movement and Pain Neuroscience EducationKnee Injury and Osteoarthritis Outcome Score (KOOS)Ql- follow up28.1 score on a scaleStandard Deviation 14
Standard Neuromuscular Exercise and OA EducationKnee Injury and Osteoarthritis Outcome Score (KOOS)Function follow-up76.7 score on a scaleStandard Deviation 14.9
Standard Neuromuscular Exercise and OA EducationKnee Injury and Osteoarthritis Outcome Score (KOOS)Pain baseline60.9 score on a scaleStandard Deviation 14
Standard Neuromuscular Exercise and OA EducationKnee Injury and Osteoarthritis Outcome Score (KOOS)Pain follow-up57.7 score on a scaleStandard Deviation 14.6
Standard Neuromuscular Exercise and OA EducationKnee Injury and Osteoarthritis Outcome Score (KOOS)Function baseline71.2 score on a scaleStandard Deviation 13.2
Standard Neuromuscular Exercise and OA EducationKnee Injury and Osteoarthritis Outcome Score (KOOS)Ql- follow up26.6 score on a scaleStandard Deviation 15.2
Standard Neuromuscular Exercise and OA EducationKnee Injury and Osteoarthritis Outcome Score (KOOS)QL baseline19.7 score on a scaleStandard Deviation 16.8
Other Pre-specified

Mechanical Temporal Summation (TS)

A 512mN weighted probe was applied at the volar wrist opposite to the index knee. Participants were asked to rate their pain on a scale from 0 (no pain) to 100 (worst imaginable pain). Then, the same stimulus was applied 10 times at a rate of 1 per second (guided by a metronome), and participants were again asked to rate their pain. Temporal Summation (TS) was defined as present if the pain rating after the repeated stimuli was higher than the initial pain rating. The TS score was calculated as the difference between the pain rating after the repeated stimuli and the initial pain rating at each timepoint.

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience EducationMechanical Temporal Summation (TS)Follow-up1.6 score on a scaleStandard Deviation 1.4
Pain Informed Movement and Pain Neuroscience EducationMechanical Temporal Summation (TS)Baseline1.8 score on a scaleStandard Deviation 1.6
Standard Neuromuscular Exercise and OA EducationMechanical Temporal Summation (TS)Follow-up1.7 score on a scaleStandard Deviation 1.4
Standard Neuromuscular Exercise and OA EducationMechanical Temporal Summation (TS)Baseline2.02 score on a scaleStandard Deviation 1.54
Other Pre-specified

Modified Charlson Comorbidity Index

to assesses the presence of comorbidities minimum score = 0, maximum = 20 with higher scores indicating greater severity.

Time frame: baseline

Other Pre-specified

Number of Participants With Medication Use

This outcome measure represents the number of participants who reported taking any medication on a regular schedule. Medication use was assessed with a yes/no response, where participants indicated whether they consistently take any prescribed or over-the-counter medications.

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Pain Informed Movement and Pain Neuroscience EducationNumber of Participants With Medication UseBaseline18 Participants
Pain Informed Movement and Pain Neuroscience EducationNumber of Participants With Medication Use8 weeks16 Participants
Standard Neuromuscular Exercise and OA EducationNumber of Participants With Medication UseBaseline9 Participants
Standard Neuromuscular Exercise and OA EducationNumber of Participants With Medication Use8 weeks10 Participants
Other Pre-specified

Other Painful Body Parts

Using a body diagram, participants will be asked to indicate any other areas where they experience pain

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience EducationOther Painful Body PartsBaselin3.6 mean number of painful jointsStandard Deviation 2.8
Pain Informed Movement and Pain Neuroscience EducationOther Painful Body Parts8 weeks4 mean number of painful jointsStandard Deviation 3.9
Standard Neuromuscular Exercise and OA EducationOther Painful Body PartsBaselin2.9 mean number of painful jointsStandard Deviation 1.9
Standard Neuromuscular Exercise and OA EducationOther Painful Body Parts8 weeks2.36 mean number of painful jointsStandard Deviation 1.5
Other Pre-specified

Pain Catastrophizing Scale (PCS)

13 questions for a total score of 52 with higher scores indicating more severe symptoms. Minimum score = 0, maximum score 52

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience EducationPain Catastrophizing Scale (PCS)Baseline11.2 score on a scaleStandard Deviation 9.6
Pain Informed Movement and Pain Neuroscience EducationPain Catastrophizing Scale (PCS)Follow-up7.4 score on a scaleStandard Deviation 7.4
Standard Neuromuscular Exercise and OA EducationPain Catastrophizing Scale (PCS)Follow-up11.1 score on a scaleStandard Deviation 6.8
Standard Neuromuscular Exercise and OA EducationPain Catastrophizing Scale (PCS)Baseline9.4 score on a scaleStandard Deviation 9.1
Other Pre-specified

Pain Intensity Measured on the Numeric Rating Scale (NRS)

This outcome measure assesses pain intensity using the Numeric Rating Scale (NRS), where participants rate their pain on a scale from 0 to 10, with higher scores indicating greater pain severity. Three ratings are recorded: average pain intensity in the past 24 hours, average pain intensity in the past week, and worst pain intensity in the past 24 hours.

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience EducationPain Intensity Measured on the Numeric Rating Scale (NRS)Follow up Pain in the past 24 hours3.0 score on a scaleStandard Deviation 2.2
Pain Informed Movement and Pain Neuroscience EducationPain Intensity Measured on the Numeric Rating Scale (NRS)Follow up worse pain in the past 24 hours3.5 score on a scaleStandard Deviation 2.7
Pain Informed Movement and Pain Neuroscience EducationPain Intensity Measured on the Numeric Rating Scale (NRS)Baseline worse pain in the past 24 hours4.9 score on a scaleStandard Deviation 1.8
Pain Informed Movement and Pain Neuroscience EducationPain Intensity Measured on the Numeric Rating Scale (NRS)Baseline Pain in the past 24 hours4.2 score on a scaleStandard Deviation 1.7
Pain Informed Movement and Pain Neuroscience EducationPain Intensity Measured on the Numeric Rating Scale (NRS)Follow-up Pain in the past week3.3 score on a scaleStandard Deviation 1.6
Pain Informed Movement and Pain Neuroscience EducationPain Intensity Measured on the Numeric Rating Scale (NRS)Baseline Pain in the past week4.2 score on a scaleStandard Deviation 1.4
Standard Neuromuscular Exercise and OA EducationPain Intensity Measured on the Numeric Rating Scale (NRS)Follow-up Pain in the past week3.1 score on a scaleStandard Deviation 1.7
Standard Neuromuscular Exercise and OA EducationPain Intensity Measured on the Numeric Rating Scale (NRS)Baseline worse pain in the past 24 hours3.9 score on a scaleStandard Deviation 2.4
Standard Neuromuscular Exercise and OA EducationPain Intensity Measured on the Numeric Rating Scale (NRS)Follow up Pain in the past 24 hours2.8 score on a scaleStandard Deviation 1.8
Standard Neuromuscular Exercise and OA EducationPain Intensity Measured on the Numeric Rating Scale (NRS)Baseline Pain in the past week3.8 score on a scaleStandard Deviation 1.9
Standard Neuromuscular Exercise and OA EducationPain Intensity Measured on the Numeric Rating Scale (NRS)Follow up worse pain in the past 24 hours3.2 score on a scaleStandard Deviation 2.2
Standard Neuromuscular Exercise and OA EducationPain Intensity Measured on the Numeric Rating Scale (NRS)Baseline Pain in the past 24 hours3.5 score on a scaleStandard Deviation 1.9
Other Pre-specified

Participant Characteristics

Ethnicity

Time frame: baseline

Population: Ethnicity: Caucasian n (%)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Pain Informed Movement and Pain Neuroscience EducationParticipant Characteristics25 Participants
Standard Neuromuscular Exercise and OA EducationParticipant Characteristics28 Participants
Other Pre-specified

Perspectives on Knee Replacement Surgery

Three questions will be asked: 1. Are your knee symptoms so severe that you wish to undergo knee replacement surgery? 2. Do you think knee replacement surgery is eventually inevitable? 3. In your opinion, what factor(s) can lead to better outcomes after knee replacement surgery?

Time frame: baseline and 8 weeks

Other Pre-specified

Perspectives on the Effectiveness of the Different Intervention Components on Managing Pain

One question will be asked of participants in each arm to rank the effectiveness of the different components of the intervention they received. e.g. Please rank the different components of the intervention you received in order of how effective they are for managing your pain. A list of the different components in each study arm will be provided e.g. education videos, strengthening exercise, mind-body techniques

Time frame: 8 weeks

Other Pre-specified

Self-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD-6)

measure of self-efficacy rated on 0-10 scale ranging from not at all confident to entirely confident

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience EducationSelf-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD-6)Baseline7.0 score on a scaleStandard Deviation 1.5
Pain Informed Movement and Pain Neuroscience EducationSelf-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD-6)Follow-up7.4 score on a scaleStandard Deviation 1.9
Standard Neuromuscular Exercise and OA EducationSelf-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD-6)Baseline6.8 score on a scaleStandard Deviation 1.8
Standard Neuromuscular Exercise and OA EducationSelf-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD-6)Follow-up7.1 score on a scaleStandard Deviation 2
Other Pre-specified

Serum Levels of Brain Derived Neurotrophic Factors (BDNF) Via Blood Analysis

a neurotrophin level measured in pg/ml

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience EducationSerum Levels of Brain Derived Neurotrophic Factors (BDNF) Via Blood AnalysisBaseline39.7 picograms per milliliterStandard Deviation 8.9
Pain Informed Movement and Pain Neuroscience EducationSerum Levels of Brain Derived Neurotrophic Factors (BDNF) Via Blood AnalysisFollow-up40.3 picograms per milliliterStandard Deviation 9
Standard Neuromuscular Exercise and OA EducationSerum Levels of Brain Derived Neurotrophic Factors (BDNF) Via Blood AnalysisBaseline39.3 picograms per milliliterStandard Deviation 11.2
Standard Neuromuscular Exercise and OA EducationSerum Levels of Brain Derived Neurotrophic Factors (BDNF) Via Blood AnalysisFollow-up39.1 picograms per milliliterStandard Deviation 10.2
Other Pre-specified

Serum Levels of Nerve Growth Factor (NGF) Via Blood Analysis

a neurotrophin level measured in pg/ml

Time frame: baseline and 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Pain Informed Movement and Pain Neuroscience EducationSerum Levels of Nerve Growth Factor (NGF) Via Blood AnalysisBaseline614 picograms per milliliterStandard Deviation 1436
Pain Informed Movement and Pain Neuroscience EducationSerum Levels of Nerve Growth Factor (NGF) Via Blood AnalysisFollow-up587 picograms per milliliterStandard Deviation 1460
Standard Neuromuscular Exercise and OA EducationSerum Levels of Nerve Growth Factor (NGF) Via Blood AnalysisBaseline534 picograms per milliliterStandard Deviation 1426
Standard Neuromuscular Exercise and OA EducationSerum Levels of Nerve Growth Factor (NGF) Via Blood AnalysisFollow-up521 picograms per milliliterStandard Deviation 1564
Other Pre-specified

Weight

Weight

Time frame: baseline and 8 weeks

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026